Mondaq USA: Anti-trust/Competition Law
Shearman & Sterling LLP
The European Commission is currently conducting in-depth investigations into whether national tax rulings breach the EU’s competition rules.
Shearman & Sterling LLP
The time taken by the European judiciary to adjudicate on cases is of increasing concern.
Holland & Knight
Boards Comprised of Active Medical Providers Are Not Entitled to Immunity from Federal Antitrust Law Unless They Are Actively Supervised by the State.
Barnes & Thornburg
In a 6-3 ruling and opinion written by Justice Anthony Kennedy, the Court upheld the U.S. Court of Appeals for the Fourth Circuit.
McDermott Will & Emery
FTC Chairwoman Edith Ramirez confirmed that focus on health care competition remains a top FTC priority.
Mayer Brown
The Commission added an example to section 240.7 of the Guides that illustrates the services and facilities covered by the Robinson-Patman Act.
McDermott Will & Emery
This decision is important for the many state-created entities across the United States that are controlled in whole or in part by market participants...
Mayer Brown
Brent Snyder, the Deputy Assistant Attorney General for Criminal Enforcement at the US Department of Justice’s Antitrust Division, recently provided advice on maintaining an effective antitrust compliance program.
Mayer Brown
After racking up record corporate criminal fines in three of the last four years, one might think that the Antitrust Division of the DOJ had made a strategic decision to focus more of its enforcement efforts on corporations.
Mayer Brown
Increasing prices can be stressful for manufacturers as they consider such questions as: What is the proper price point? How will customers react? What will the competition do?
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
The Federal Trade Commission ("FTC") on Monday completed its review of Novartis AG’s ("Novartis") proposed $16 billion acquisition of GlaxoSmithKline’s ("GSK") oncology drug portfolio with an announced consent decree that requires limited divestitures of BRAF- and MEK-inhibitor drugs used to treat melanoma, ovarian, colorectal, non-small cell lung, and other cancers.
McDermott Will & Emery
The NDPs in Amex's agreements with merchants prevent merchants from attempting "to induce or 'steer' a customer" from paying with non-AmEx credit cards...
McDermott Will & Emery
The U.S. Court of Appeals for the Ninth Circuit affirmed an Idaho federal district court’s decision ordering the divestiture of a physician practice group that had been acquired by a competing health system.
Dickinson Wright PLLC
Early into the 114th Congress, multiple bills have already been introduced that would repeal the insurance industry’s limited antitrust exemption granted by the McCarran-Ferguson Act.
Dickinson Wright PLLC
Undeterred by Judge Presnell's ruling, on February 11, plaintiffs filed a Second Amended Complaint, again asserting antitrust claims for price fixing and "boycott."
Dickinson Wright PLLC
On January 6, two Michigan Congressmen – Representative John Conyers (D-Mich) and Representative Dan Benishek (R-Mich) – introduced the "Quality Health Care Coalition Act of 2015."
Dickinson Wright PLLC
On January 22, the DOJ Antitrust Division issued a press release detailing the results of its criminal antitrust enforcement program for fiscal year 2014 (which ended September 30, 2014).
Patterson Belknap Webb & Tyler LLP
Since we last reported on state and federal investigations into recent generic drug price increases, the investigations have moved forward against Philadelphia-based Lannett Co.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Mintz Levin’s Bruce Sokler and Helen Kim have prepared an Alert that reviews the Supreme Court’s reasoning in North Carolina State Board of Dental Examiners vs. FTC...
Venable LLP
The case involved a claim of antitrust immunity by the North Carolina State Board of Dental Examiners (Board) under the state-action doctrine established in Parker v. Brown.
Latest Video
Most Popular Recent Articles
Proskauer Rose LLP
Today, the U.S. Supreme Court resolved a circuit split on the crucial issue of who has standing to sue for false advertising under the Lanham Act.
Patterson Belknap Webb & Tyler LLP
The long trial in United States v. American Express has come to an end: on September 18, 2014, the parties exchanged post-trial briefing and on October 9, 2014, the court held oral argument.
WilmerHale
On February 2, 2015, the Antitrust Division of the U.S. Department of Justice (DOJ) took another step towards clarifying the antitrust rules applicable to standard essential patents (SEPs).
WilmerHale
Patent trolls are currently under intense scrutiny by lawmakers, regulators, academics, and industry players.
Patterson Belknap Webb & Tyler LLP
After the Ninth Circuit’s decision on January 15, 2015, Major League Baseball maintains its exemption from the antitrust laws.
BakerHostetler
Branded drug companies naturally want the exclusivity period to last as long as possible.
Mayer Brown
Compliance with US antitrust laws requires firms to consider not only conduct that falls within the scope of the Sherman Act and the Clayton Act, but also conduct that may violate the Federal Trade Commission Act (the "Act"), particularly Section 5.
Milbank, Tweed, Hadley & McCloy LLP
In this briefing, we highlight some key areas of antitrust enforcement to be prepared for in 2015.
Schnader Harrison Segal & Lewis LLP
On January 21, 2015, the Supreme Court issued its much-anticipated decision in Gelboim v. Bank of America Group.
Morrison & Foerster LLP
The assertion of standard essential patents (SEPs) by patent-holders has raised patent, contract, and competition issues in jurisdictions around the world.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners